HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.
Nachbaur
David
D
Angelova
Olga
O
Loacker
Klaus
K
Auberger
Jutta
J
Clausen
Johannes
J
Schumacher
Petra
P
Gastl
Günther
G
Kircher
Brigitte
B
D001782:Blood Donors; D015234:HLA-A Antigens / Q000276:immunology*; D015789:HLA-A2 Antigen; D006801:Humans; D007263:Infusions, Parenteral; D007938:Leukemia / Q000276:immunology* / Q000601:surgery / Q000628:therapy*; D017710:Lymphocyte Transfusion; D012008:Recurrence; D033581:Stem Cell Transplantation; D015996:Survival Rate; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D015234:HLA-A Antigens; C435939:HLA-A*02:01 antigen; D015789:HLA-A2 Antigen